Eye Care Formulary - FOI Response Register

1.    Please can you provide the name and email address of the medicines management team member who led on the Eye Care (Chapter 11) formulary review when it was last reviewed?

This is carried out on our behalf by NHS Grampian as we use their Formulary

2.    Please can you provide the name and email address of the member of the Health Board Medicines management team who is currently responsible for overseeing Eye Care formularies?

See response to Q1

3.    Do you have an area prescribing committee/Medicines Optimisation Committees/ Medicines advisory group or similarly named group that manages your drug formulary decisions?

See response to Q1

4.    Please can you provide the names and email addresses of all members of these formulary groups?

See response to Q1

5.    Please can you provide copies of the previous two minutes from the Area Prescribing Committee/ Medicines Optimisation Committees/ Medicines advisory group or similarly named groups meetings?

See response to Q1

6.    I would be grateful if you could confirm for which products within Chapter 11 (Eye) of your formulary, you have a primary care rebate in place, when the agreement commenced, the rebate amount and the end date?

In accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 25(1) as the information requested is accessible without submitting a request under FOISA s 1(1). The information you have requested is available here:

https://www.nss.nhs.scot/

7.    Does the Health Board have a deficit forecast for 2023/2024 financial year? If so, how much is this deficit? How much is the forecast deficit for 2024/2025 financial year?

No deficit in prescribing budget. N/A for deficit figure. No forecast for 2024/25 available.

8.    What is the value of your Health Board’s planned savings from the Medicines management drug prescribing budget in the financial year: 2023-2024? And 2024 – 2025?

£150,000 for 2023-2024. No savings target for 2024-2025 set.